Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,727 | 56,060 | 180,211 | 325,389 | 461,225 |
| Marketable Securities | 215,799 | 334,561 | 451,505 | 447,229 | 583,675 |
| Receivables | 35,448 | 27,524 | 36,615 | 18,786 | 24,241 |
| Inventories | 49,285 | 58,755 | 56,676 | 50,381 | 24,599 |
| TOTAL | $375,052 | $495,681 | $742,047 | $852,074 | $1,101,134 |
| Non-Current Assets | |||||
| PPE Net | 24,146 | 30,505 | 36,432 | 41,580 | 32,504 |
| Intangibles | 332,885 | 707,333 | 919,245 | 820,219 | 820,953 |
| Other Non-Current Assets | 52,000 | 26,928 | 48,289 | 53,213 | 52,379 |
| TOTAL | $409,031 | $764,766 | $1,003,966 | $915,012 | $905,836 |
| Total Assets | $784,083 | $1,260,447 | $1,746,013 | $1,767,086 | $2,006,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,770 | 16,590 | 15,062 | 12,028 | 11,002 |
| Accrued Expenses | 33,646 | 22,595 | 45,708 | 32,596 | 36,261 |
| Other current liabilities | 2,031 | 3,224 | 8,326 | 179,327 | 5,759 |
| TOTAL | $72,831 | $66,299 | $95,029 | $263,335 | $71,709 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,936 | 13,864 | 16,342 | 30,498 | 10,977 |
| Other Non-Current Liabilities | 701,974 | 681,654 | 944,150 | 939,053 | 1,119,225 |
| TOTAL | $705,903 | $687,554 | $949,680 | $940,847 | $1,144,274 |
| Total Liabilities | $778,734 | $753,853 | $1,044,709 | $1,204,182 | $1,215,983 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 301,998 | 297,852 | 267,952 | 247,079 | 221,183 |
| Common Shares | 302 | 294 | 268 | 227 | 221 |
| Retained earnings | -2,695,302 | -2,148,926 | -1,839,075 | -1,532,340 | -1,218,092 |
| Other shareholders' equity | 457 | 422 | 219 | -4,765 | -1,087 |
| TOTAL | $5,349 | $506,594 | $701,304 | $562,904 | $790,987 |
| Total Liabilities And Equity | $784,083 | $1,260,447 | $1,746,013 | $1,767,086 | $2,006,970 |